SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $60,000 | -67.9% | 83,536 | -67.6% | 0.00% | – |
| Q2 2019 | $187,000 | +149.3% | 257,519 | +317.8% | 0.00% | – |
| Q1 2019 | $75,000 | -47.9% | 61,640 | -17.2% | 0.00% | – |
| Q3 2017 | $144,000 | -41.2% | 74,481 | -17.9% | 0.00% | – |
| Q2 2017 | $245,000 | -46.5% | 90,681 | -18.9% | 0.00% | -100.0% |
| Q1 2017 | $458,000 | +14.5% | 111,811 | +1.1% | 0.00% | 0.0% |
| Q4 2016 | $400,000 | -3.1% | 110,581 | +16.9% | 0.00% | 0.0% |
| Q3 2016 | $413,000 | – | 94,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 7,600,000 | $9,234,000 | 7.03% |
| Samsara BioCapital, LLC | 3,750,000 | $4,556,000 | 3.58% |
| CAXTON CORP | 277,245 | $337,000 | 0.31% |
| BVF INC/IL | 2,287,860 | $2,780,000 | 0.31% |
| Eventide Asset Management | 5,965,455 | $7,248,000 | 0.25% |
| Telemetry Investments, L.L.C. | 197,564 | $240,000 | 0.12% |
| NEA Management Company, LLC | 1,298,274 | $1,584,000 | 0.08% |
| RP Management, LLC | 129,517 | $158,000 | 0.08% |
| Palo Alto Investors LP | 1,162,473 | $1,412,000 | 0.06% |
| Fosun International Ltd | 725,000 | $863,000 | 0.06% |